f.yildiz
TL2 Moderator · Bergen
Contributes reviews on supplier material. Based in Bergen.
Joined 2 February 2025 · last posted 9d
99 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 31 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #62 · Compounds › Repair & healing peptides · 19 Jul 2026 · 1 like I read post #60 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 16 Jul 2026 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #34 · Compounds › Retatrutide · 14 Jul 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How shortages have affected compounding permissions Replied, post #34 · Access › Shortages · 13 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: what we got wrong in an earlier session Replied, post #78 · Evidence › Journal club · 13 Jul 2026 · 30 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #39 · Practice › Side effects · 9 Jul 2026 · 31 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Submitting a sample: the process end to end Replied, post #53 · Sourcing › Independent verification · 2 Jul 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Cost and turnaround: different services have different pricing and turnaround…
-
Tracking a shortage from primary sources rather than rumour Replied, post #75 · Access › Shortages · 29 Jun 2026 · 4 likes post #74 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
Tracking intake honestly when appetite is absent Replied, post #60 · Nutrition & Training › Protein & intake · 15 Jun 2026 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Electrolyte supplements: which ones do anything Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 10 Jun 2026 · 7 likes This follows post #24 rather than contradicting it. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific.…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #104 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #57 · Practice › Storage & stability · 2 Jun 2026 · 23 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #44 · Safety › Contraindications · 20 May 2026 · 14 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #4 · Analytics › Home & field testing · 10 May 2026 · 15 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #52 · Practice › Administration · 30 Apr 2026 · 6 likes post #51 answers the question as asked. The question underneath it is different. A genuinely late dose: the labelling generally says that if the next dose is more than…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #5 · Outcomes › Progress reports · 27 Apr 2026 · 1 like Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Why this subcategory is stricter about sourcing than most Replied, post #22 · Compounds › Secretagogues & GH axis · 25 Apr 2026 · 3 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #51 · Sourcing › Logistics · 24 Apr 2026 · 13 likes post #50 answers the question as asked. The question underneath it is different. Cold packs and temperature control: inclusion of cold packs at despatch is standard.…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #157 · Access › Pricing · 24 Apr 2026 · 10 likes On post #153 — agreed on the reasoning, with one qualification. Subscription services and subscriptions: some online clinics bundle compounds into subscription models…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #105 · Practice › Reconstitution · 20 Apr 2026 · 1 like This follows post #102 rather than contradicting it. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #25 · Practice › Reconstitution · 19 Apr 2026 · 0 likes On post #21 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #30 · Evidence › Journal club · 15 Apr 2026 · 6 likes Picking up post #27: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #74 · Practice › Interactions · 4 Apr 2026 · 0 likes This follows post #71 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #112 · Clinical › Bloodwork · 27 Mar 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #3 · Practice › Dosing & titration · 14 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #85 · Access › Pricing · 10 Feb 2026 · 0 likes Coming back to post #83, because the follow-up matters more than the original answer. Cost per milligram is the only comparison that survives format differences, but…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #14 · Outcomes › Progress reports · 7 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #34 · Start Here › Welcome · 23 Jan 2026 · 4 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Preprint servers and what screening they do Replied, post #30 · Evidence › Preprints · 20 Jan 2026 · 3 likes Picking up post #27: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #51 · Sourcing › Regulatory · 19 Jan 2026 · 0 likes post #50 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #86 · Practice › Interactions · 9 Jan 2026 · 0 likes On post #82 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
A partial dose because the pen emptied mid-injection Replied, post #35 · Practice › Administration · 8 Jan 2026 · 17 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #26 · Meta › Site feedback · 23 Dec 2025 · 10 likes post #25 answers the question as asked. The question underneath it is different. Community norms: if you think a norm has drifted or is not being followed consistently,…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #4 · Practice › Storage & stability · 20 Dec 2025 · 0 likes Worth separating two things that post #3 runs together. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly…
-
Tracking a preprint to publication: a worked example Replied, post #114 · Evidence › Preprints · 11 Dec 2025 · 1 like post #113 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Persistent vomiting and the threshold for seeking help Replied, post #78 · Safety › Adverse events · 29 Nov 2025 · 0 likes post #77 is right about the mechanism and I think understates the practical bit. How to document: date, exact symptom or event, severity, duration, outcome, any medical…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #33 · Documentation › Doc review · 24 Nov 2025 · 27 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Long-time reader, first-time poster Replied, post #19 · Lounge › Introductions · 17 Nov 2025 · 3 likes Worth separating two things that post #15 runs together. Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to…
-
Pen dose counters: what a click does and does not guarantee Replied, post #36 · Devices › Pens & autoinjectors · 14 Nov 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What a purity-only report leaves out Replied, post #86 · Sourcing › Independent verification · 14 Nov 2025 · 0 likes On post #82 — agreed on the reasoning, with one qualification. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #16 · Pharmacology › Pharmacokinetics · 9 Nov 2025 · 20 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #45 · Compounds › Oral incretins · 28 Oct 2025 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #89 · Start Here › Welcome · 21 Oct 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Hypertension improvement and when medication needs revisiting Replied, post #64 · Clinical › Comorbidities · 16 Sep 2025 · 7 likes Picking up post #61: that is the part I would want checked first. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled,…
-
Documentation that appears only after payment Replied, post #25 · Sourcing › Red flags · 15 Sep 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #18 · Data & Tools › Datasets · 7 Sep 2025 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Thyroid function tests during substantial weight change Replied, post #49 · Clinical › Bloodwork · 2 Sep 2025 · 20 likes post #48 is right about the mechanism and I think understates the practical bit. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #58 · Analytics › Home & field testing · 30 Aug 2025 · 11 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Are there stupid questions here? A staff answer, at length Replied, post #130 · Start Here › Welcome · 30 Aug 2025 · 6 likes Coming back to post #128, because the follow-up matters more than the original answer. Off-topic posts that do not belong here belong in the Lounge instead. You are not…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #14 · Practice › Storage & stability · 26 Aug 2025 · 31 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #9 · Sourcing › Vendor reports · 22 Aug 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #42 · Practice › Reconstitution · 15 Aug 2025 · 2 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #64 · Compounds › Secretagogues & GH axis · 14 Aug 2025 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #163 · Compounds › Tirzepatide · 12 Aug 2025 · 3 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Are there stupid questions here? A staff answer, at length Replied, post #57 · Start Here › Welcome · 10 Aug 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Travel coolers and how long they really hold Replied, post #54 · Devices › Cold chain · 5 Aug 2025 · 0 likes This follows post #51 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #15 · Sourcing › Red flags · 1 Aug 2025 · 20 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #22 · Pharmacology › Receptor biology · 1 Aug 2025 · 19 likes This follows post #19 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Titles that describe the question, not the situation Replied, post #55 · Start Here › How to Ask · 24 Jul 2025 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #13 · Regional › European Union · 20 Jul 2025 · 0 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #55 · Compounds › Oral incretins · 28 Jun 2025 · 0 likes Worth separating two things that post #51 runs together. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #20 · Access › Insurance & coverage · 20 Jun 2025 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #138 · Evidence › Journal club · 15 Jun 2025 · 4 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
An emergency department visit, described afterwards Replied, post #31 · Safety › Adverse events · 15 Jun 2025 · 0 likes Picking up post #28: that is the part I would want checked first. Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #88 · Access › Insurance & coverage · 13 Jun 2025 · 4 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
A supplier that answers analytical questions with restated claims Replied, post #87 · Sourcing › Red flags · 31 May 2025 · 17 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #25 · Compounds › Repair & healing peptides · 28 May 2025 · 18 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Requesting a translation of an existing page Replied, post #20 · Documentation › Wiki requests · 23 May 2025 · 0 likes Coming back to post #18, because the follow-up matters more than the original answer. Translation suggestions: if a maintained page should exist in another language,…
-
Pregnancy as an absolute contraindication Replied, post #103 · Safety › Contraindications · 21 May 2025 · 0 likes post #102 answers the question as asked. The question underneath it is different. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
-
Follow-up: What other technical communities get right that we do not Replied, post #98 · Lounge › Off topic · 15 May 2025 · 6 likes I read post #96 twice before replying, because I had assumed the opposite. Science communication: if you come across an interesting science paper or article about…
-
Publishing an inconvenient result: a case study Replied, post #17 · Sourcing › Independent verification · 8 May 2025 · 2 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #46 · Sourcing › Independent verification · 4 May 2025 · 16 likes Picking up post #43: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Documentation that appears only after payment Replied, post #40 · Sourcing › Red flags · 2 May 2025 · 31 likes post #39 is right about the mechanism and I think understates the practical bit. Evasion when asked: if a supplier does not clarify when asked specifically for method…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #26 · Clinical › Comorbidities · 1 May 2025 · 9 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Follow-up: Documentation that appears only after payment Replied, post #2 · Sourcing › Red flags · 15 Apr 2025 · 3 likes Worth separating two things that the opening post runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Scheduled maintenance and what will be unavailable Replied, post #92 · Meta › Announcements · 31 Mar 2025 · 4 likes Worth separating two things that post #88 runs together. Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #130 · Compounds › Semaglutide · 17 Mar 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #39 · Compounds › Tirzepatide · 14 Mar 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Why plausible mechanism is not evidence of effect Started this topic · Compounds › Repair & healing peptides · 8 Mar 2025 · 23 likes Asking directly, because I could not find a straight answer: Why plausible mechanism is not evidence of effect Session topic: STEP 2 ( Lancet , 2021). Please read it…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #156 · Sourcing › Regulatory · 6 Mar 2025 · 5 likes post #155 is right about the mechanism and I think understates the practical bit. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #116 · Sourcing › Regulatory · 4 Mar 2025 · 27 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Assessing a warm arrival: the decision process Started this topic · Sourcing › Logistics · 6 Feb 2025 · 15 likes Posting this under the heading it deserves: Assessing a warm arrival: the decision process Everything below is what sits behind that. A logistics question, since the…
-
What we do not know about retatrutide, listed explicitly Replied, post #73 · Compounds › Retatrutide · 28 Jan 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #68 · Compounds › Other compounds · 20 Jan 2025 · 6 likes post #67 answers the question as asked. The question underneath it is different. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Fixed versus detachable needles: the trade-offs Replied, post #121 · Devices › Syringes & needles · 18 Jan 2025 · 0 likes I read post #119 twice before replying, because I had assumed the opposite. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume…
-
Building a sensible monitoring schedule with your prescriber Replied, post #27 · Clinical › Bloodwork · 19 Dec 2024 · 3 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Two sessions a week versus four: what the evidence supports Replied, post #32 · Nutrition & Training › Resistance training · 12 Dec 2024 · 9 likes This follows post #29 rather than contradicting it. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier…
-
Why "any advice?" is the least effective ending for a post Replied, post #94 · Start Here › How to Ask · 1 Dec 2024 · 30 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Revisiting: Moderation log format change Replied, post #21 · Meta › Announcements · 9 Nov 2024 · 12 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #127 · Clinical › Comorbidities · 29 Oct 2024 · 14 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Requesting a page: what makes a good request — what changed since Replied, post #124 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes post #123 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
Progressive overload when the scale is falling — one year on Replied, post #15 · Nutrition & Training › Resistance training · 30 Aug 2024 · 3 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Correlation in a self-tracked dataset: what it can support Replied, post #27 · Research Methods › Statistics · 21 Aug 2024 · 3 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Reading a meta-analysis you disagree with, fairly Replied, post #9 · Evidence › Meta-analyses · 6 Aug 2024 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
The mass-error checker and its intended scope Replied, post #142 · Data & Tools › Calculators · 21 Jul 2024 · 7 likes Worth separating two things that post #138 runs together. Titration planning: a calculator that shows you the escalation schedule for different starting and ending…
-
Pen wastage and its effect on real cost Replied, post #3 · Access › Pricing · 22 Jun 2024 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Assessing a warm arrival: the decision process — one year on Replied, post #136 · Sourcing › Logistics · 2 Jun 2024 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.